Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study
Figure 1
Glucose lowering therapy strategies adopted in the 195 patients with available prescription data. A large proportion of patients were treated with oral mono, dual, or triple therapies while the percentage of patients treated with insulin alone or in association with other drugs was lower and was higher in patients with severe CKD compared to moderate ones.
